ArticleCureus2025
Psychogenic Polydipsia Presenting as Recurrent Hyponatremic Seizures in a Patient With Schizoaffective Disorder.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Psychogenic polydipsia is a rare but potentially fatal condition characterized by excessive water consumption leading to dilutional hyponatremia and neurological complications. It is most frequently seen in patients with chronic psychotic disorders such as schizophrenia and schizoaffective disorder. We present a 42-year-old man with a 22-year history of schizoaffective disorder who developed recurrent generalized tonic-clonic seizures and confusion. Initial evaluation revealed severe hyponatremia, but the cause could not be identified. He was admitted to an intensive care unit and treated with hypertonic saline and antiepileptic medication. After stabilization and discharge, he experienced difficulty in sleeping and hallucinatory behavior and was subsequently readmitted under psychiatric care. During routine workup, laboratory investigations confirmed hyponatremia again, which was then further investigated for causes and found. The patient had hypotonic hyponatremia with low serum osmolality and inappropriately dilute urine, consistent with psychogenic polydipsia. Endocrine and systemic causes, including diabetes insipidus, adrenal insufficiency, and hypothyroidism, were excluded. Drug history was taken in detail to rule out any drugs causing hyponatremia and substance abuse was ruled out as well. The patient was observed during his ward stay and it was found that he would drink excessive amounts of water, exceeding 15 liters daily, including water from storage tanks and washing areas. Management focused on cautious correction of serum sodium to prevent osmotic demyelination, positive and negative reinforcement for fluid restriction, seizure prophylaxis, and optimization of psychiatric treatment. He underwent nine sessions of bilateral electroconvulsive therapy for refractory affective and psychotic symptoms and participated in behavioral modification sessions aimed at reducing water-seeking behavior. Sodium levels normalized within 10 days, and no further seizures occurred. At the six-month follow-up, the patient remained stable under supervised care, compliant with medication, and maintained a restricted fluid intake below two liters daily. This case underscores the importance of early recognition of psychogenic polydipsia as a reversible cause of recurrent seizures and hyponatremia in psychiatric populations. Vigilant monitoring of fluid intake, interdisciplinary management, and behavioral intervention are crucial to achieving sustained recovery and preventing recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.